Deborah M. Messemer
CIK: 0001754424
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jul 15, 2026TPG
TPG Inc.
Award(A)Direct4.2K shares- - Jun 18, 2026ALLO
Allogene Therapeutics, Inc.
Award(A)DirectRestricted Stock Unit
95.4K shares- - May 19, 2026PYPL
PayPal Holdings, Inc.
Award(A)Direct6.3K shares- - Jul 16, 2025TPG
TPG Inc.
Sale(S)Direct1.8K shares at avg. $56.32$101K - Jul 15, 2025TPG
TPG Inc.
Award(A)Direct2.8K shares- - Jun 18, 2025ALLO
Allogene Therapeutics, Inc.
Award(A)DirectRestricted Stock Unit
95.4K shares- - Jun 10, 2025ALLO
Allogene Therapeutics, Inc.
Sale(S)Direct36.9K shares at avg. $1.42$52K - Jun 6, 2025PYPL
PayPal Holdings, Inc.
Sale(S)Direct3.8K shares at avg. $73.00$277K - Jun 5, 2025PYPL
PayPal Holdings, Inc.
Award(A)Direct3.8K shares- - Feb 18, 2025ALLO
Allogene Therapeutics, Inc.
Sale(S)Direct13.3K shares at avg. $2.43$32K - Jan 14, 2025TPG
TPG Inc.
Sale(S)Direct1.7K shares at avg. $61.91$105K - Dec 9, 2024ALLO
Allogene Therapeutics, Inc.
Sale(S)Direct9.1K shares at avg. $2.18$20K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 15, 2026 |  TPG TPG Inc. | Award(A) | 4,181 | - | $0 | Direct |
| Jun 18, 2026 |  ALLO Allogene Therapeutics, Inc. | Award(A) Restricted Stock Unit | 95,400 | - | - | Direct |
| May 19, 2026 |  PYPL PayPal Holdings, Inc. | Award(A) | 6,275 | - | $0 | Direct |
| Jul 16, 2025 | TPG TPG Inc. | Sale(S) | 1,796 | $56.32 | $101,148 | Direct |
| Jul 15, 2025 | TPG TPG Inc. | Award(A) | 2,762 | - | - | Direct |
| Jun 18, 2025 | ALLO Allogene Therapeutics, Inc. | Award(A) Restricted Stock Unit | 95,400 | - | - | Direct |
| Jun 10, 2025 | ALLO Allogene Therapeutics, Inc. | Sale(S) | 36,885 | $1.42 | $52,377 | Direct |
| Jun 6, 2025 | PYPL PayPal Holdings, Inc. | Sale(S) | 3,795 | $73.00 | $277,036 | Direct |
| Jun 5, 2025 | PYPL PayPal Holdings, Inc. | Award(A) | 3,795 | - | - | Direct |
| Feb 18, 2025 | ALLO Allogene Therapeutics, Inc. | Sale(S) | 13,313 | $2.43 | $32,351 | Direct |
| Jan 14, 2025 | TPG TPG Inc. | Sale(S) | 1,695 | $61.91 | $104,931 | Direct |
| Dec 9, 2024 | ALLO Allogene Therapeutics, Inc. | Sale(S) | 9,136 | $2.18 | $19,916 | Direct |
1-12 of 12 transactions
About MESSEMER DEBORAH M.
MESSEMER DEBORAH M. (SEC CIK 0001754424) files insider reports with the SEC as Director of TPG Inc. (TPG), Director of Allogene Therapeutics, Inc. (ALLO) and Director of PayPal Holdings, Inc. (PYPL).
Signal8 holds 10 ownership filings by MESSEMER DEBORAH M., all Form 4s, filed between Dec 10, 2024 and Jul 17, 2026. Those filings report 12 transactions, from Dec 9, 2024 to Jul 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on MESSEMER DEBORAH M.'s filings is in FORT WORTH, TX.
Recent filings by MESSEMER DEBORAH M.
- Jul 15, 2026: Grant or award of TPG shares (Form 4, code A).
- Jun 18, 2026: Grant or award of ALLO derivative securities (Form 4, code A).
- May 19, 2026: Grant or award of PYPL shares (Form 4, code A).
- Jul 16, 2025: Open-market sale of TPG shares (Form 4, code S).
- Jul 15, 2025: Grant or award of TPG shares (Form 4, code A).
Other insiders filing for TPG Inc. (TPG)
- Andre Axel, Chief Financial Officer
- WINKELRIED JON, Chief Executive Officer
- Vazquez-Ubarri Anilu, Chief Operating Officer
- Trujillo David, Director
- Sisitsky Todd Benjamin, President
- Sarvananthan Ganendran, Director